|
⚲
|
| Keyboard |
| Bain Capital Life Sciences III General Partner LLC
✚
|
|
|---|---|
| CIK # | 0001952106 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001952106] | |
| 3 | [0001952106] | |
| 4 | [0001952106] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Heartflow Inc HTFL
Common Stock
|
2026-02-04 | Sell | 2,000,000 | $28.05 | 56,100,000 |
|
Heartflow Inc HTFL
Common Stock
|
2025-08-11 | Conversion | 12,014,234 | ||
|
Heartflow Inc HTFL
Common Stock
|
2025-08-11 | Conversion | 433,924 | $15.20 | 6,595,645 |
|
Heartflow Inc HTFL
Subordinated Convertible Promissory Note · derivative
|
2025-08-11 | Conversion | $0.00 | ||
|
Heartflow Inc HTFL
Series F Preferred Stock · derivative
|
2025-08-11 | Conversion | 35,081,564 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Pre-Funded Warrant (right to buy) · derivative
|
2024-12-13 | Buy | 1,632,653 | $24.50 | 39,999,998 |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 450,000 | $22.00 | 9,900,000 |
|
Kyverna Therapeutics Inc KYTX
Series B Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 12,351,087 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 2,713,868 |